AMLX
Common StockAmylyx Pharmaceuticals, Inc.
Reported Shares
4.5M
Position Mix
No options reported
Reported Value
$130.1M
Portfolio Weight
19.05%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$683.1M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
AMLX
Common StockAmylyx Pharmaceuticals, Inc.
Reported Shares
4.5M
Position Mix
No options reported
Reported Value
$130.1M
Portfolio Weight
19.05%
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
529.3K
Position Mix
No options reported
Reported Value
$52.4M
Portfolio Weight
7.67%
IMMX
Common StockImmix Biopharma, Inc.
Reported Shares
4.7M
Position Mix
No options reported
Reported Value
$48.5M
Portfolio Weight
7.10%
PHVS
Common StockPharvaris N.V.
Reported Shares
1.4M
Position Mix
No options reported
Reported Value
$44.2M
Portfolio Weight
6.47%
PCVX
Common StockVaxcyte, Inc.
Reported Shares
772.3K
Position Mix
No options reported
Reported Value
$43.9M
Portfolio Weight
6.43%
CELC
Common StockCelcuity Inc.
Reported Shares
513.8K
Position Mix
No options reported
Reported Value
$40.9M
Portfolio Weight
5.98%
IRON
Common StockDisc Medicine, Inc.
Reported Shares
612.7K
Position Mix
No options reported
Reported Value
$40.1M
Portfolio Weight
5.87%
CADL
Common StockCandel Therapeutics, Inc.
Reported Shares
3.5M
Position Mix
No options reported
Reported Value
$36.3M
Portfolio Weight
5.31%
JAZZ
Common StockJazz Pharmaceuticals plc
Reported Shares
150.3K
Position Mix
No options reported
Reported Value
$34.8M
Portfolio Weight
5.10%
MNPR
Common StockMonopar Therapeutics
Reported Shares
312.4K
Position Mix
No options reported
Reported Value
$24.9M
Portfolio Weight
3.64%
VIR
Common StockVir Biotechnology, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$22.8M
Portfolio Weight
3.34%
TRVI
Common StockTrevi Therapeutics, Inc.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$22.5M
Portfolio Weight
3.30%
XFOR
Common StockX4 Pharmaceuticals, Inc
Reported Shares
7.4M
Position Mix
No options reported
Reported Value
$21.4M
Portfolio Weight
3.13%
ALMS
Common StockALUMIS INC.
Reported Shares
2.9M
Position Mix
No options reported
Reported Value
$21.1M
Portfolio Weight
3.09%
SGMT
Common StockSagimet Biosciences Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$19.8M
Portfolio Weight
2.90%
DYN
Common StockDyne Therapeutics, Inc.
Reported Shares
837.2K
Position Mix
No options reported
Reported Value
$13.5M
Portfolio Weight
1.97%
ANRO
Common StockAlto Neuroscience, Inc.
Reported Shares
518.1K
Position Mix
No options reported
Reported Value
$13.2M
Portfolio Weight
1.94%
RARE
Common StockUltragenyx Pharmaceutical Inc.
Reported Shares
758.8K
Position Mix
No options reported
Reported Value
$11.4M
Portfolio Weight
1.67%
ZURA
Common StockZura Bio Ltd
Reported Shares
2M
Position Mix
No options reported
Reported Value
$8.5M
Portfolio Weight
1.24%
IKT
Common StockInhibikase Therapeutics, Inc.
Reported Shares
3.9M
Position Mix
No options reported
Reported Value
$8.0M
Portfolio Weight
1.16%